The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 13,201–13,300 of 31,469
Rout, D., Dash, U. C., Kanhar, S., Swain, S. K., & Sahoo, A. K. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113099 · Cited by 25
Rubia tinctorum root extracts: chemical profile and management of type II diabetes mellitus
Eltamany, E. E., Nafie, M. S., Khodeer, D. M., El-Tanahy, A. H. H., Abdel-Kader, M. S., Badr, J. M., & Abdelhameed, R. F. A. (2020) · RSC Advances · doi:10.1039/d0ra03442h · Cited by 25
Vázquez-Bourgón, J., Alario, M. I., Son, J. M.-V., Gómez‐Revuelta, M., Ayesa‐Arriola, R., Ruiz, M. J., de la Foz, V. O., & Crespo‐Facorro, B. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.08.009 · Cited by 26
Abdulmalek, S. A., Fessal, M., & El-Sayed, M. M. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113439 · Cited by 25
Succurro, E., Fiorentino, T. V., Miceli, S., Perticone, M., Sciacqua, A., Andreozzi, F., & Sesti, G. (2020) · Diabetes Care · doi:10.2337/dc20-1401 · Cited by 24
Maroofi, M., & Nasrollahzadeh, J. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01399-0 · Cited by 29
Diboun, I., Al-Mansoori, L., Al-Jaber, H., Albagha, O., & Elrayess, M. A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa732 · Cited by 26
Watt, G. P., de la Cerda, I., Pan, J., Fallon, M. B., Beretta, L., Loomba, R. S., Lee, M., McCormick, J. B., & Fisher‐Hoch, S. P. (2020) · Hepatology Communications · doi:10.1002/hep4.1603 · Cited by 25
Kim, K., Song, Y., Oh, T. J., Choi, S. H., & Jang, H. C. (2020) · Nutrients · doi:10.3390/nu12113365 · Cited by 25
Hajizadeh‐Sharafabad, F., Tarighat‐Esfanjani, A., Ghoreishi, Z., & Sarreshtedari, M. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520004997 · Cited by 26
Ram, H., Kumar, P., Purohit, A., Kashyap, P., Kumar, S., Kumar, S., Singh, G., Alqarawi, A. A., Hashem, A., Allah, E. F. A., et al. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00547-2 · Cited by 25
Kawakami, Y., Watanabe, Y. S., Mazuka, M., Yagi, N., Sawazaki, A., Koganei, M., Natsume, M., Kuriki, K., Morimoto, T., Asai, T., et al. (2021) · Nutrition · doi:10.1016/j.nut.2020.111128 · Cited by 32
Jobira, B., Frank, D. N., Silveira, L. J., Pyle, L. L., Kelsey, M. M., Garcia‐Reyes, Y., Robertson, C. E., Ir, D., Nadeau, K. J., & Cree‐Green, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245219 · Cited by 25
Mokhlesi, B., Tjaden, A. H., Temple, K. A., Edelstein, S. L., Sam, S., Nadeau, K. J., Hannon, T. S., Manchanda, S., Mather, K. J., Kahn, S. E., et al. (2021) · Diabetes Care · doi:10.2337/dc20-2127 · Cited by 28
Jovanović, G. K., Mrakovčić-Šutić, I., Žeželj, S. P., Horvat, I. B., Šuša, L., Rahelić, D., & Majanović, S. K. (2021) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2021/6649142 · Cited by 28
Fénichel, P., Coquillard, P., Brücker-Davis, F., Marchand, P., Cano-Sancho, G., Boda, M., Antignac, J., Iannelli, A., Gugenheim, J., Bizec, B. L., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106400 · Cited by 27
Moshkovits, Y., Rott, D., Chetrit, A., & Dankner, R. S. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01284-9 · Cited by 25
Chen, F., Liao, Y., Chen, M., Yin, H., Chen, G., Huang, Q., Chen, L., Yang, X., Zhang, W., Wang, P., et al. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00535-0 · Cited by 25
Galderisi, A., Moran, A., Evans‐Molina, C., Martino, M., Santoro, N., Caprio, S., & Cobelli, C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab344 · Cited by 27
Nishimiya, N., Tajima, K., Imajo, K., Kameda, A., Yoshida, E., Togashi, Y., Aoki, K., Inoue, T., Nakajima, A., Utsunomiya, D., et al. (2021) · Internal Medicine · doi:10.2169/internalmedicine.7134-21 · Cited by 26
Visaria, A., Pai, S., Cheung, M., & Ahlawat, S. (2021) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002215 · Cited by 26
Kashiwada, M., Nakaishi, S., Usuda, A., Miyahara, Y., Katsumoto, K., Katsura, K., Terakado, I., Jindo, M., Nakajima, S., Ogawa, S., et al. (2021) · Journal of Natural Medicines · doi:10.1007/s11418-021-01537-7 · Cited by 25
Kanbay, M., Şentürk, B. G., Ertuğlu, L. A., Dağel, T., Afşar, B., İncir, S., Baygül, A., Covic, A. C., Andrés-Hernando, A., Sánchez‐Lozada, L. G., et al. (2021) · Nutrients · doi:10.3390/nu13061916 · Cited by 28
Yu, P., Huang, L., Wang, Z., Meng, X., & Yu, X. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s312489 · Cited by 24
Wang, Z., Zheng, K. I., Wang, X., Qiao, J., Li, Y., Zhang, L. R., Zheng, M., & Wu, J. (2021) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2021.05.008 · Cited by 26
Verma, A., Nelson, M. T., DePaolo, R. W., Hampe, C. S., & Roth, C. L. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00855-7 · Cited by 27
Lee, S. K., Park, C. Y., Kim, J., Kim, D., Choe, H., Kim, J.-H., Hong, J. P., Lee, Y. J., Heo, Y., Park, H. S., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab780 · Cited by 26
Sack, C., Ferrari, N., Friesen, D., Haas, F., Klaudius, M., Schmidt, L., Torbahn, G., Wulff, H., & Joisten, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11010277 · Cited by 25
Wang, F., Zheng, R., Li, L., Xu, M., Lu, J., Zhao, Z., Li, M., Wang, T., Wang, S., Bi, Y., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.802114 · Cited by 26
Body composition, physical fitness and cardiovascular risk factors in 9-year-old children
Henriksson, P., Sandborg, J., Henström, M., Nyström, C. D., Ek, E., Ortega, F. B., & Löf, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-06578-w · Cited by 29
Associations of lower-carbohydrate and lower-fat diets with mortality among people with prediabetes
Li, L., Shan, Z., Wan, Z., Li, R., Geng, T., Lu, Q., Zhu, K., Qiu, Z., Zhang, X., Liu, Y., et al. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac058 · Cited by 26
Interpersonal Trauma and Risk of Incident Cardiovascular Disease Events Among Women
Thurston, R. C., Chang, Y., Matthews, K. A., Harlow, S. D., Khoudary, S. R. E., Janssen, İ., & Derby, C. A. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024724 · Cited by 27
Telle‐Hansen, V. H., Gaundal, L., Høgvard, B., Ulven, S. M., Holven, K. B., Byfuglien, M. G., Måge, I., Knutsen, S. H., Ballance, S., Rieder, A., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.796362 · Cited by 30
Ore, A., Adewale, A. A., Kehinde, S. A., Faniyi, T. O., Oladeji, A. D., Rufus, P. C., Akande, A. A., & Chukwuemeka, I. E. (2022) · Advances in Redox Research · doi:10.1016/j.arres.2022.100038 · Cited by 26
Effect of Coffee and Tea Consumption on Adolescent Weight Control: An Interventional Pilot Study
Moran‐Lev, H., Cohen, S., Zelber‐Sagi, S., Mayer, E. M., Anafy, A., Yerushalmy‐Feler, A., & Lubetzky, R. (2022) · Childhood Obesity · doi:10.1089/chi.2022.0032 · Cited by 32
The Joint Secular Trends of Sleep Quality and Diabetes Among US Adults, 2005-2018
Wang, X., Ma, H., Gupta, S., Heianza, Y., Fonseca, V. A., & Qi, L. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac401 · Cited by 26
Ferro, Y., Pujia, R., Mazza, E., Lascala, L., Lodari, O., Maurotti, S., Pujia, A., & Montalcini, T. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03579-1 · Cited by 25
Vena, W., Carrone, F., Delbarba, A., Akpojiyovbi, O., Pezzaioli, L. C., Facondo, P., Cappelli, C., Leonardi, L., Balzarini, L., Farina, D., et al. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01901-8 · Cited by 25
Salvatori, B., Linder, T., Eppel, D., Morettini, M., Burattini, L., Göbl, C. S., & Tura, A. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01649-8 · Cited by 26
ALI, M. I., Hussein, M., Magdy, R., Khamis, A., Al‐Azayem, S. A., Othman, A. M., Ahmed, A., & Osama, W. (2022) · BMC Neurology · doi:10.1186/s12883-022-02966-x · Cited by 31
Balikcioglu, P. G., Trub, C. J., Balikcioglu, M., Ilkayeva, O., White, P. J., Muehlbauer, M. J., Bain, J. R., Armstrong, S., & Freemark, M. (2022) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.388 · Cited by 26
MOTS-c repairs myocardial damage by inhibiting the CCN1/ERK1/2/EGR1 pathway in diabetic rats
Wang, M., Wang, G., Pang, X., Ma, J., Yuan, J., Pan, Y., Fu, Y., Laher, I., & Li, S. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1060684 · Cited by 25
Fiorentino, T. V., Vito, F. D., Suraci, E., Marasco, R., Hribal, M. L., Luzza, F., & Sesti, G. (2023) · Obesity · doi:10.1002/oby.23653 · Cited by 24
The association between endocrine disrupting chemicals and MAFLD: Evidence from NHANES survey
Lei, R., Xue, B., Tian, X., Liu, C., Li, Y., Zheng, J., & Luo, B. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114836 · Cited by 28
Moore, R., Feehily, C., Killeen, S. L., Yelverton, C. A., Geraghty, A. A., Walsh, C. J., O’Neill, I. J., Nielsan, I. B., Lawton, E. M., Sánchez-Gallardo, R., et al. (2023) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2023.100994 · Cited by 27
An early prediction model for gestational diabetes mellitus based on metabolomic biomarkers
Razo-Azamar, M., Nambo‐Venegas, R., Meraz‐Cruz, N., Guevara‐Cruz, M., Ibarra‐González, I., Vela-Amieva, M. B., Delgadillo‐Velazquez, J., Santiago, X. C., Escobar, R. F., Vadillo‐Ortega, F., et al. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01098-7 · Cited by 29
Bhargava, R., Luur, S., Flores, M. R., Emini, M., Prechtl, C., & Goldstone, A. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad061 · Cited by 20
Sex-specific impact of maternal obesity on fetal placental macrophages and cord blood triglycerides
Shook, L. L., James, K. E., Roberts, D. J., Powe, C. E., Perlis, R. H., Thornburg, K. L. R., O’Tierney-Ginn, P. F., & Edlow, A. G. (2023) · Placenta · doi:10.1016/j.placenta.2023.08.001 · Cited by 26
Arellano-García, L., Macarulla, M. T., Cuevas‐Sierra, A., Martínez, J. A., Portillo, M. P., & Milton‐Laskibar, I. (2023) · Food & Function · doi:10.1039/d3fo01307c · Cited by 25
Xiao, Q., Durbin, J. R., Bauer, C., Yeung, C. H. C., & Figueiro, M. G. (2023) · Diabetes Care · doi:10.2337/dc23-1034 · Cited by 25
Dietary Patterns in Acne and Rosacea Patients—A Controlled Study and Comprehensive Analysis
Guertler, A., Volsky, A., Eijkenboom, Q. L., Fiedler, T., French, L. E., & Reinholz, M. (2023) · Nutrients · doi:10.3390/nu15204405 · Cited by 26
Hannemann, J., Laing, A., Middleton, B., Schwedhelm, E., Marx, N., Federici, M., Kastner, M., Skene, D. J., & Böger, R. H. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.107011 · Cited by 26
Andreoli, M. F., Fittipaldi, A. S., Castrogiovanni, D. C., Francesco, P. N. D., Valdivia, S., Heredia, F., Ribet-Travers, C., Méndez, I., Fasano, M. V., Schiöth, H. B., et al. (2023) · European Journal of Nutrition · doi:10.1007/s00394-023-03304-8 · Cited by 26
Circulating Galectin-3 levels in women with polycystic ovary syndrome: A meta-analysis
Bahreiny, S. S., Bastani, M., Aghaei, M., Dabbagh, M. R., & Mahdizade, A. H. (2024) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2023.10.003 · Cited by 28
Breast Cancer Risk After Bariatric Surgery and Influence of Insulin Levels
Kristensson, F. M., Andersson‐Assarsson, J. C., Peltonen, M., Jacobson, P., Ahlin, S., Svensson, P., Sjöholm, K., Carlsson, L. M. S., & Taube, M. (2024) · JAMA Surgery · doi:10.1001/jamasurg.2024.1169 · Cited by 26
Anaforoğlu, İ., Topbaş, M., & Algün, E. (2011) · PubMed · doi:10.3275/7681 · Cited by 27
Relation of Acanthosis Nigricans to Metabolic Syndrome in Overweight and Obese Women
Ayaz, T., Şahin, S. B., & Şahin, O. Z. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0145 · Cited by 24
Etxeberría, U., Arias, N., Boqué, N., Romo‐Hualde, A., Macarulla, M. T., Portillo, M. P., Milagro, F. I., & Martínez, J. A. (2015) · Food & Function · doi:10.1039/c5fo00473j · Cited by 25
Yu, J. H., Ahn, J. H., Yoo, H. J., Seo, J. A., Kim, S. G., Choi, K. M., Baik, S. H., Choi, D. S., Shin, C., & Kim, N. H. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.30.6.846 · Cited by 25
Ikuta, T., Saito, S., Tani, H., et al. (2015) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2015.1056510 · Cited by 25
Borges, C. C., Salles, A. F., Bringhenti, I., Souza‐Mello, V., Mandarim‐de‐Lacerda, C. A., & Águila, M. B. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500398 · Cited by 25
Kudolo, G. B., Wang, W.-D., Elrod, R., Barrientos, J., HAASE, A., & BLODGETT, J. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2005.10.001 · Cited by 25
Schuster, I., Vinet, A., Karpoff, L., Startun, A., Jourdan, N., Dauzat, M., Nottin, S., & Pérez‐Martin, A. (2011) · Obesity · doi:10.1038/oby.2011.270 · Cited by 26
Audı́, L., Carrascosa, A., Esteban, C., Fernández‐Cancio, M., Andaluz, P., Yeste, D., Espadero, R., Granada, M., Wollmann, H. A., Fryklund, L., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0150 · Cited by 25
CORTELAZZI, D., Marconi, A. M., Guazzi, M., et al. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0482-x · Cited by 25
Nena, E., Steiropoulos, P., Τzouvelekis, Α., Tsara, V., Hatzizisi, O., Kyriazis, G., Froudarakis, Μ. E., Trakada, G., Παπάνας, Ν., & Bouros, D. E. (2010) · Respiration · doi:10.1159/000295903 · Cited by 25
Hu, S., Yao, M., Peterson, B. S., Xu, D., Hu, J., Tang, J., Fan, B., Liao, Z., Yuan, T., Li, Y., et al. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3073-1 · Cited by 25
Lakhdar, N., Denguezli, M., Zaouali, M., Zbidi, A., Tabka, Z., & Bouassida, A. (2013) · Inflammation · doi:10.1007/s10753-013-9661-8 · Cited by 25
Sheu, W. H., Chin, H.-M. L., Lee, W., Wan, C., Su, H.-Y., & Lang, H.-F. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.12.002 · Cited by 25
Metabolic parameters after BioEnterics Intragastric Balloon placement in obese patients
Donadio, F., Sburlati, L. F., Masserini, B., Lunati, E., Lattuada, E., Zappa, M. A., Mozzi, E., Beck‐Peccoz, P., & Orsi, E. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345708 · Cited by 25
Kraemer‐Aguiar, L. G., Maranhao, P. A., Sicuro, F. L., & Bouskela, E. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.209 · Cited by 25
Improved n-3 fatty acid status does not modulate insulin resistance in fa/fa Zucker rats
Gillam, M. E., Noto, A. D., Zahradka, P. C., & Taylor, C. G. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.09.008 · Cited by 25
Impaired Glucose Tolerance in Pediatric Burn Patients at Discharge From the Acute Hospital Stay
Fram, R. Y., Cree‐Green, M., Wolfe, R. R., Barr, D., & Herndon, D. N. (2010) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e3181eebe63 · Cited by 25
Fujikawa, Y., Tominaga, K., Fujii, H., Machida, H., Okazaki, H., Yamagami, H., Tanigawa, T., Watanabe, K., Watanabe, T., Fujiwara, Y., et al. (2012) · Digestion · doi:10.1159/000341418 · Cited by 25
Relationship of fetuin-A levels to weight-dependent insulin resistance and type 2 diabetes mellitus
Erdmann, J., Salmhofer, H., Knauß, A., Mayr, M., Wagenpfeil, S., Sypchenko, O., Luppa, P. B., & SCHUSDZIARRA, V. (2012) · Regulatory Peptides · doi:10.1016/j.regpep.2012.02.004 · Cited by 25
Serum leptin and its relation to anthropometric measures of obesity in pre-diabetic Saudis
Al‐Daghri, N. M., Al-Attas, O. S., Al-Rubeaan, K. A., Mohieldin, M., Al-Katari, M., Jones, A. F., & Kumar, S. (2007) · Cardiovascular Diabetology · doi:10.1186/1475-2840-6-18 · Cited by 27
eNOS polymorphism associated with metabolic syndrome in children and adolescents
de Miranda, J. A., Belo, V. D. A., Souza-Costa, D. C., Lanna, C. M. M., & Tanus-Santos, J. E. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1456-y · Cited by 25
DeBoer, M. D., Mendoza, J. P., Liu, L., Ford, G., Yu, P. L., & Gaston, B. M. (2011) · Sleep And Breathing · doi:10.1007/s11325-011-0499-8 · Cited by 25
Tso, T. K., Huang, H., Chang, C., Liao, Y.-J., & Huang, W. (2004) · Clinical Rheumatology · doi:10.1007/s10067-004-0908-5 · Cited by 25
Boumaiza, I., Omezzine, A., Rejeb, J., Rebhi, L., Rejeb, N. B., Nabli, N., Abdelaziz, A. B., & Bouslama, A. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0035 · Cited by 25
Hinton, P. S., Rector, R. S., Donnelly, J. E., SMITH, B. K., & Bailey, B. W. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2009.156 · Cited by 25
Bidulescu, A., Morris, A. A., Stoyanova, N., Meng, Y., Vaccarino, V., Quyyumi, A. A., & Gibbons, G. H. (2014) · Frontiers in Public Health · doi:10.3389/fpubh.2014.00193 · Cited by 26
Paediatric Non-Alcoholic Fatty Liver Disease: Impact on Patients and Mothers’ Quality of Life
Mazzone, L., Postorino, V., Peppo, L. D., Corte, C. D., Lofino, G., Vassena, L., Fatta, L. M., Armando, M., Bedogni, G., Vicari, S., et al. (2013) · Hepatitis Monthly · doi:10.5812/hepatmon.7871 · Cited by 25
Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease
Lebensztejn, D. M., Białokoz‐Kalinowska, I., Kłusek-Oksiuta, M., Tarasów, E., Wojtkowska, M., & Kaczmarski, M. G. (2014) · Advances in Medical Sciences · doi:10.1016/j.advms.2013.08.003 · Cited by 25
Nasry, M., Abo‐Youssef, A. M., & El‐Latif, H. A. A. (2013) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1016/j.bjbas.2013.09.008 · Cited by 25
Endocrinopathies in transfusion‐associated iron overload
Kim, M. K., Lee, J. W., Baek, K. H., Song, K. H., Kwon, H., Oh, K. W., Jang, E., Kang, M. I., & Lee, K. W. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04495.x · Cited by 25
Metabolic effects of regular physical exercise in healthy population
Caro, J., Navarro, I., Romero, P., Lorente, R. I., Priego, M. A., Martínez‐Hervás, S., Real, J. T., & Ascaso, J. F. (2013) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2012.11.006 · Cited by 25
Sağsöz, N., Orbak, Z., Noyan, V., Yücel, A., Uçar, B., & Yıldız, L. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.07.008 · Cited by 26
Kraemer‐Aguiar, L. G., Maranhao, P. A., Cyrino, F. Z. G. A., & Bouskela, E. (2010) · Microvascular Research · doi:10.1016/j.mvr.2010.08.004 · Cited by 25
Mortality associated with alcohol-related liver disease
Trimble, G., Zheng, L., Mishra, A., Kalwaney, S., Mir, H. M., & Younossi, Z. M. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12432 · Cited by 26
Preservation of Beta-Cell Function in Type 2 Diabetes
Nyalakonda, K., Sharma, T., & Ismail‐Beigi, F. (2010) · Endocrine Practice · doi:10.4158/ep10112.ra · Cited by 25
Aldawsari, H. M., Hanafy, A., Labib, G. S., & Badr, J. M. (2014) · Zeitschrift für Naturforschung C · doi:10.5560/znc.2014-0047 · Cited by 25
Characterization of metabolically healthy obese Brazilians and cardiovascular risk prediction
Pimentel, A. D. C., Scorsatto, M., de Oliveira, G. M. M., Rosa, G., & Luiz, R. R. (2015) · Nutrition · doi:10.1016/j.nut.2014.12.024 · Cited by 25
Cohen, T. R., Hazell, T. J., Vanstone, C. A., Plourde, H., Rodd, C. J., & Weiler, H. A. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-383 · Cited by 28
Anan, F., Masaki, T., Eto, T., Iwao, T., Shimomura, T., Umeno, Y., Eshima, N., Saikawa, T., & Yoshimatsu, H. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02103.x · Cited by 25
Guzzaloni, G., Minocci, A., Marzullo, P., & Liuzzi, A. (2009) · International Journal of Obesity · doi:10.1038/ijo.2008.271 · Cited by 25
Yu, S. H., Park, S., Kim, H., Park, S., Yim, C. H., Han, K. O., Yoon, H. K., Jang, H. C., Chung, H. Y., & Kim, S. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.963 · Cited by 25
Rate of Weight Gain and Cardiometabolic Abnormalities in Children and Adolescents
Calarge, C. A., Xie, D., Fiedorowicz, J. G., Burns, T. L., & Haynes, W. G. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.05.051 · Cited by 24
Role of Adipose Tissue in Determining Muscle Mass in Patients With Chronic Kidney Disease
Castaneda‐Sceppa, C., Sarnak, M. J., Wang, X., Greene, T., Madero, M., Kusek, J. W., Beck, G. J., Kopple, J. D., Levey, A. S., & Menon, V. (2007) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2007.05.006 · Cited by 25
Circulating Fractalkine Levels Predict the Development of the Metabolic Syndrome
Yin, X., Zhang, S., Dan, Y., Pan, Q., Dong, X., Jiaqiang, Z., Fenping, Z., & Li, H. (2014) · International Journal of Endocrinology · doi:10.1155/2014/715148 · Cited by 25
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
